Memphis Pharmaceuticals (Egypt) Price Prediction

MPCI Stock   52.72  0.21  0.40%   
At this time, the value of RSI of Memphis Pharmaceuticals' share price is approaching 35. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Memphis Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

35

 
Oversold
 
Overbought
The successful prediction of Memphis Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Memphis Pharmaceuticals and does not consider all of the tangible or intangible factors available from Memphis Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Memphis Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Using Memphis Pharmaceuticals hype-based prediction, you can estimate the value of Memphis Pharmaceuticals from the perspective of Memphis Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Memphis Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Memphis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Memphis Pharmaceuticals after-hype prediction price

    
  EGP 52.72  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Memphis Pharmaceuticals Estimiated After-Hype Price Prediction Volatility

As far as predicting the price of Memphis Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Memphis Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Memphis Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Memphis Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Memphis Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Memphis Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Memphis Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.99 
7.11
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
52.72
52.72
0.00 
0.00  
Notes

Memphis Pharmaceuticals Hype Timeline

Memphis Pharmaceuticals is now traded for 52.72on Egyptian Exchange of Egypt. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Memphis is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.99%. %. The volatility of related hype on Memphis Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 52.72. Assuming the 90 days trading horizon the next forecasted press release will be uncertain.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Memphis Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Memphis Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Memphis Pharmaceuticals' future price movements. Getting to know how Memphis Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Memphis Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
MPCIMemphis Pharmaceuticals 0.00 0 per month 2.52  0.1  12.93 (4.98) 47.18 
PACHPaint Chemicals Industries 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
EIUDEgyptians For Investment 0.00 0 per month 1.75  0.13  5.00 (4.55) 9.76 
GTHEGlobal Telecom Holding 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ATLCAl Tawfeek Leasing 0.00 0 per month 1.55  0.10  4.77 (2.53) 9.69 
ORASOrascom Construction PLC 0.00 0 per month 1.23  0.04  3.79 (2.27) 15.06 
EGASNatural Gas Mining 0.00 0 per month 2.93  0.11  8.96 (5.00) 39.94 
EMFDEmaar Misr for 0.00 0 per month 2.13  0.05  4.99 (3.34) 12.29 
ATQAMisr National Steel 0.00 0 per month 1.89  0.13  4.78 (3.42) 15.29 
AIVCBAl Arafa Investment 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

Memphis Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Memphis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Memphis using various technical indicators. When you analyze Memphis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Story Coverage note for Memphis Pharmaceuticals

The number of cover stories for Memphis Pharmaceuticals depends on current market conditions and Memphis Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Memphis Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Memphis Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Complementary Tools for Memphis Stock analysis

When running Memphis Pharmaceuticals' price analysis, check to measure Memphis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Memphis Pharmaceuticals is operating at the current time. Most of Memphis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Memphis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Memphis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Memphis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules